This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seely, E. W. Articles by Williams, G. H. Search for Related Content PubMed PubMed Citation Articles by Seely, E. W. Articles by Williams, G. H.

Hypertension, Vol 13, 31-37, Copyright © 1989 by American Heart Association

ARTICLES

Angiotensin-mediated renin suppression is altered in non-modulating hypertension

EW Seely, TJ Moore, S Rogacz, MS Gordon, RE Gleason, NK Hollenberg and GH Williams
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

Plasma renin activity (PRA) suppression by angiotensin II (Ang II), the "short feedback loop," has been shown to be blunted in essential hypertension. Non-modulators comprise 50% of normal- and high-renin essential hypertensive individuals and are defined by their abnormal adrenal and renal responses to infused Ang II. This study sought to determine if the abnormal Ang II suppression of PRA in essential hypertension is specific to non-modulators. We measured PRA suppression during infusion of Ang II in 22 normotensive and 32 hypertensive (16 modulators and 16 non-modulators) subjects. A significant correlation between basal PRA and the fall in PRA in response to Ang II infusion was seen in the normotensives (r = -0.934, p less than 0.001) and modulators (r = -0.831, p less than 0.001) but not in the non- modulators (r = -0.275, p = 0.304). However, after 3 days of converting enzyme inhibition therapy, the correlation between basal PRA and decrement in PRA was significant in the non-modulators (r = -0.762, p less than 0.01). Thus, the abnormal PRA suppression documented previously in hypertensive individuals is a defect specific to non- modulators and is corrected with converting enzyme inhibition therapy.

This article has been cited by other articles:

				M. S Gordon, D. A Price, and N. K Hollenberg Blunted suppression of plasma renin activity in diabetes Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 252 - 256. [Abstract] [PDF]

				M. R. Goldberg, T. E. Bradstreet, E. J. McWilliams, W. K. Tanaka, S. Lipert, T. D. Bjornsson, S. A. Waldman, B. Osborne, L. Pivadori, G. Lewis, et al. Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients Hypertension, January 1, 1995; 25(1): 37 - 46. [Abstract] [Full Text]